Why Does Clostridium difficile Infection Recur?

被引:10
|
作者
Orenstein, Robert [1 ]
Patron, Roberto L. [1 ]
Seville, M. Teresa [1 ]
机构
[1] Mayo Clin Arizona, Div Infect Dis, Phoenix, AZ USA
来源
JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION | 2019年 / 119卷 / 05期
关键词
Clostridium difficile; osteopathic; pathogenesis; recurrent infection; SPORULATION;
D O I
10.7556/jaoa.2019.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clostridium (or Clostridioides) difficile infection affects more than 500,000 people annually in the United States, one-third of whom have recurrent symptoms. The evolution of C difficile as a resilient pathogen has to do with its ability to persist in the environment and in the host, leading to recurrence and environmental spread. Understanding the mechanisms by which this microbe interacts with the environment, the host, and the gut microbiota are critical to solving this problem. This article presents a brief clinical vignette; discusses the current state of understanding of colonization, transmission, and recurrence; and considers the role the host plays in eliminating this infection. The understanding of these mechanisms and application of osteopathic principles has the potential to improve patient outcomes.
引用
收藏
页码:322 / 326
页数:5
相关论文
共 50 条
  • [1] Community Clostridium difficile Clostridium difficile infection
    Wilcox, Mark H.
    Planche, Tim
    BRITISH MEDICAL JOURNAL, 2009, 338
  • [2] Does PPI therapy predispose to Clostridium difficile infection?
    Pant, Chaitanya
    Madonia, Phillip
    Minocha, Anil
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (09) : 555 - 557
  • [3] Does My Patient Have Clostridium difficile Infection?
    Peterson, Lance R.
    Robicsek, Ari
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (03) : 176 - W41
  • [4] Clostridium difficile Ribotype Does Not Predict Severe Infection
    Walk, Seth T.
    Micic, Dejan
    Jain, Ruchika
    Lo, Eugene S.
    Trivedi, Itishree
    Liu, Eugene W.
    Almassalha, Luay M.
    Ewing, Sarah A.
    Ring, Cathrin
    Galecki, Andrzej T.
    Rogers, Mary A. M.
    Washer, Laraine
    Newton, Duane W.
    Malani, Preeti N.
    Young, Vincent B.
    Aronoff, David M.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (12) : 1661 - 1668
  • [5] Does PPI therapy predispose to Clostridium difficile infection?
    Chaitanya Pant
    Phillip Madonia
    Anil Minocha
    Nature Reviews Gastroenterology & Hepatology, 2009, 6 : 555 - 557
  • [6] The difficile in Clostridium difficile infection
    Akoghlanian, Garabet
    Lakshmi, Seetha
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 77 : 14 - 15
  • [7] Clostridium difficile Infection
    Shin, Jae Hyun
    Chaves-Olarte, Esteban
    Warren, Cirle A.
    MICROBIOLOGY SPECTRUM, 2016, 4 (03):
  • [8] Clostridium difficile infection
    Groschel, DHM
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1996, 33 (03) : 203 - 245
  • [9] Clostridium difficile Infection
    Heinlen, Latisha
    Ballard, Jimmy D.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 340 (03): : 247 - 252
  • [10] Clostridium difficile infection
    不详
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2014, 145 (07): : 784 - 784